Regis Resources (ASX: RRL) drops Vault Minerals bid, letting Genesis Minerals’s A$5.6bn offer proceed
Read More Pharma Industry News Could pediatric anaphylaxis become the next growth opportunity for ALK Abelló’s EURneffy franchise? Find out how EURneffy’s UK pediatric approval could strengthen ALK Abelló’s allergy strategy and challenge auto-injectors. bySoujanya RaviJune 18, 2026